Eli Lilly stock has soared on a new growth wave driven by its diabetes and obesity care treatments. While this has made profit-taking in Lilly stock tempting, the company has several catalysts ahead.
New drugs from public and private companies are expected to saturate the obesity drug market. Novo Nordisk and Eli Lilly are currently dominating the weight loss drug market, but biopharmaceutical ...
Though not launching to consumers, it could be part of future health products. You might want a ... everything you need to know before buying a new Apple tablet. There are dozens of streaming ...
Tributes paid to Wexford woman who died after receiving serious injuries in house fire – ‘She had a heart of gold’ ‘An inspirational force of nature’ –Tributes paid to Kilkenny mum-of ...